Latest stories on ABVX
Arquitos Capital Q2 2026 Investor Letter
Seeking Alpha68 · bullishearnings
ABVX Spotlights Seven Obefazimod Abstracts at UEG Week 2026, Featuring Phase 3 Maintenance and Long-Term Phase 2 Follow-Up
October 1, 2026
MarketChameleon67 · bullishproduct/pr
Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
GlobeNewswire56 · neutralproduct/pr
Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
Business Insider56 · neutralproduct/pr
Abivax Updates Share Capital and Voting Rights Structure as of August 31, 2026
TipRanks50 · neutralgeneral
Abivax: Priced Right Ahead Of 2 Make-Or-Break Catalysts
Seeking Alpha58 · neutralproduct/pr
Abivax price target lowered to $118 from $140 at Wedbush
The Fly34 · bearishanalyst
Abivax price target lowered to $151 from $155 at Truist
The Fly48 · neutralanalyst
Abivax appoints Chris Rabbat as Chief Medical Officer
The Fly56 · neutralgeneral
Abivax reports 1H results
Business Insider50 · neutralgeneral
EQS-News: Abivax Presents Business Updates and First Half 2026 Financial Results
Business Insider50 · neutralearnings
Abivax Presents Business Updates and First Half 2026 Financial Results
Business Insider55 · neutralgeneral
Abivax Presents Business Updates and First Half 2026 Financial Results
GlobeNewswire56 · neutralearnings
Abivax options imply 6.0% move in share price post-earnings
The Fly56 · neutralearnings
Here are the major earnings after the close Monday
Seeking Alpha50 · neutralearnings
Will Abivax Stock (ABVX) Rise or Fall After Q2 Earnings?
TipRanks48 · neutralearnings
Goldman Sachs initiates Abivax stock coverage with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Why is Abivax stock climbing today?
Investing.com Markets50 · neutralgeneral
Abivax initiated with a Buy at Goldman Sachs
The Fly61 · neutralanalyst
Ulcerative Colitis Market Outlook: 5 Late-Stage Drug Candidates to Watch | DelveInsight
GlobeNewswire50 · neutralgeneral
Abivax Updates Share Capital and Voting Rights as of July 31, 2026
TipRanks50 · neutralgeneral
Abivax Gains FDA Alignment on NDA Path for Obefazimod—Paving Way for 2026 Filing in Ulcerative Colitis
MarketChameleon73 · bullishproduct/pr
Why is Abivax stock climbing today?
Investing.com Markets50 · neutralgeneral
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
StockTitan67 · bullishproduct/pr